Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro
Chandra Kumar Elechalawar,1 Md Nazir Hossen,1 Priya Shankarappa,2 Cody J Peer,2 William D Figg,2 J David Robertson,3 Resham Bhattacharya,4 Priyabrata Mukherjee1,5 1Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; 2Clinical Pharmacology Program...
Saved in:
Main Authors: | Elechalawar CK, Hossen MN, Shankarappa P, Peer CJ, Figg WD, Robertson JD, Bhattacharya R, Mukherjee P |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/00dc7e5e6b6f43c99c08922e28d657cc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies
by: Spadavecchia J, et al.
Published: (2016) -
The unique pancreatic stellate cell gene expression signatures are associated with the progression from acute to chronic pancreatitis
by: Cheng Hu, et al.
Published: (2021) -
IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth
by: Jiahui Li, et al.
Published: (2021) -
Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma
by: Chiaki Uchida, et al.
Published: (2021) -
Regulation of Pancreatic Fibrosis by Acinar Cell-Derived Exosomal miR-130a-3p via Targeting of Stellate Cell PPAR-γ
by: Wang Q, et al.
Published: (2021)